Sun Pharmaceutical Industries Limited
NSE: SUNPHARMA₹1,760.00
Price as of 9 Oct 2026
52-Week Price Spectrum14.0% below high
52W Low: ₹1,583.70
52W High: ₹2,046.90
246 trading sessions · daily high/low through 9 Oct 2026
Market Cap
₹422,283 Cr
CONSOLIDATED
P/E Ratio
34.92x
Available
P/B Ratio
5.03x
Available
ROE
—
Not available
Business Performance
Revenue (TTM)
₹59,910.5 Cr
Profit / PAT (TTM)
₹12,117.0 Cr
Basic EPS (TTM)
₹50.40
Net Margin
19.0%
Financial Health
Net Worth Reported 31 Mar 2026 · Balance Sheet Gold
₹83,879.7 Cr
Total Debt Reported 31 Mar 2026 · Balance Sheet Gold
₹4,081.6 Cr
Net Debt Reported 31 Mar 2026 · Balance Sheet Gold
₹-5,688.9 Cr
Debt to Equity Reported 31 Mar 2026 · Financial Ratios Gold
0.05x
Current Ratio Reported 31 Mar 2026 · Financial Ratios Gold
2.82x
Returns & Valuation
Return on Equity (ROE)
— Not available
ROCE
Not available yet
Price to Earnings (P/E)
34.92x
Price to Book (P/B)
5.03x
Book Value Per Share (BVPS) Reported 31 Mar 2026 · Balance Sheet Gold
₹349.60
Understand These Numbers
Price-to-Earnings (P/E) Ratio
Price investors pay for each ₹1 of recent annual earnings per share.
Price-to-Book (P/B) Ratio
Compares the current share price to the accounting net asset value per share.
Return on Equity (ROE)
Measures how efficiently the company generated net profit on shareholder equity.
Debt to Equity
Total borrowings relative to net worth; not applicable to banks or lending institutions.
Stockerboard shows only metrics available under its certified data contract. Unavailable and not-applicable metrics are never estimated.
Data Basis & Provenance
Price Session
2026-10-09
Earnings Period
2026-06-30
Reporting Scope
CONSOLIDATED
Data Basis
Certified Dossier V2 and reported Balance Sheet / Financial Ratios Gold; each available balance sheet metric shows its date.